BoardVitals - Cardiovascular

MAY 15, 2022

The Cardiovascular Disease Maintenance of Certification Exam can be difficult, with a pass rate in 2021 of 88%. Heart Failure and Cardiomyopathy 19% Valvular Disease 15% Pericardial Disease 3% Congenital Heart Disease 3% Vascular Diseases 5% Systemic Hypertension and Hypotension 8.5% What does the exam cover?

Certification 52

Certification Congenital Heart Disease Coronary Artery Disease Cardiovascular Disease 52

DAIC

MARCH 25, 2025

Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for treatingt adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF). Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52

DAIC

MARCH 25, 2025

Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for treatingt adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF). Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

All About Cardiovascular System and Disorders

FEBRUARY 24, 2024

Arrhythmogenic Cardiomyopathy was better known as Arrhythmogenic Right Ventricular Dysplasia or ARVD and sometimes as Arrhythmogenic Right Ventricular Cardiomyopathy or ARVC earlier. A study published in JACC has compared the phenotypic expression and clinical outcomes in patients with arrhythmogenic cardiomyopathy [2].

Cardiomyopathy 52

Cardiomyopathy Chest Pain Arrhythmia Heart Transplant 52

European Journal of Heart Failure

SEPTEMBER 24, 2023

Abstract Cardiomyopathies represent significant contributors to cardiovascular morbidity and mortality. Furthermore, medications targeting core disease processes and/or their downstream adverse effects have been introduced for several cardiomyopathies.

Document 40

Document Cardiomyopathy Sudden Cardiac Death Heart Failure 40

DAIC

JUNE 19, 2024

A burgeoning group of vendor-neutral, software-only AI-ECG platform companies has also emerged, including Cardiologs (acquired by Philips in 2021), Cardiomatics (Poland), and Accurkardia (US), whose algorithms can interpret ECG signals from 1-3 lead ambulatory devices up to a traditional 12-lead resting ECG. Active vendors in this space (i.e.,

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

DAIC

OCTOBER 2, 2024

Director of the Hypertrophic Cardiomyopathy Center at the Lahey Hospital and Medical Center. Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM. CVrg: Heart Failure 2020-2029, p 44; Maron et al. CVrg: Heart Failure 2020-2029, p 44; Maron et al.

Cardiomyopathy 40

Cardiomyopathy Sudden Cardiac Death Biomarkers Heart Failure 40

EMS 12-Lead

JUNE 1, 2022

LBBB and Heart Failure ECG findings of uncomplicated LBBB (that is, no criteria met for m-Sgarbossa criteria) are so ubiquitous in clinical medicine that it’s easy to overlook the nefarious sequelae of this pathology when no circumstance of OMI are present. Left bundle branch block-induced cardiomyopathy: Myth or reality?

Heart Failure 52

Heart Failure Myocardial Infarction Bradycardia Chest Pain 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Journal of the American Heart Association

MARCH 13, 2025

BackgroundSparce data suggest higher mortality in heart failure (HF) with left ventricular ejection fraction (EF) >65% to 70%. Methods and ResultsThere were 5576 patients enrolled in the Swedish HF registry between 2017 and 2021 and included in the study; 21% had EF 60%, 5% EF 65%, and 1.5%

Preserved Ejection Fraction 70

Preserved Ejection Fraction Heart Failure Peripheral Arterial Disease Cardiomyopathy 70

Dr. S. Venkatesan MD

APRIL 3, 2025

For women with significant heart disease (e.g., severe mitral stenosis, pulmonary hypertension, or cardiomyopathy), prolonged labor could strain the heart excessively, potentially leading to decompensation, heart failure, or arrhythmias. 2021 Apr 13;77(14):1799-1812. J Am Coll Cardiol. doi: 10.1016/j.jacc.2021.01.057.

Heart Disease 45

Heart Disease Blood Pressure Heart Failure Aortic 45

Open Heart

DECEMBER 2, 2024

Introduction Heart failure with reduced ejection fraction (HFrEF) guidelines recommend ‘four pillars’ of medical therapy and device therapy if left ventricular ejection fraction (LVEF) remains ≤35% after 3 months optimum medical therapy. Results Between June 2021 and August 2022, 49 patients were recruited.

ACE Inhibitor 52

ACE Inhibitor Heart Failure Cardiomyopathy Outcomes 52